Alleviation of insulitis in NOD mice is associated with expression of transgenic MHC E molecules on primary antigen-presenting cells

Immunology
B Pilström, J Böhme

Abstract

Major histocompatibility complex (MHC) class II genes are important in the pathogenesis of insulin-dependent diabetes mellitus (IDDM) both in the mouse and in man. The non-obese diabetic (NOD) mouse, which is a good model for human IDDM, has a particular MHC class II with an A complex consisting of A alpha d and the unique A beta g7 chain, as well as an absent E molecule due to a deletion in the Ea promoter region. Transgenic insertion of a functional Ea gene protects against insulitis and diabetes, but when the transgene expression is restricted to certain compartments of the immune system by deleting parts of the promoter region, the protection against insulitis is disrupted. We have analysed three promoter-mutated lines where one lacks expression on B cells and has a reduced expression on approximately 1/3 of the dendritic cells and macrophages (Sma), one lacks thymic cortical expression and has a slightly reduced B-cell expression (delta X), and one lacks expression in the thymic medulla, on macrophages, dendritic cells and about half of the B cells (delta Y). None of these lines is protected against insulitis, but Sma and delta X display a reduced intensity of insulitis, with an average of 10-15% of the islets infiltrated ...Continue Reading

References

Jun 21, 1990·Nature·R M SlatteryJ F Miller
Sep 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A DornD Mathis
May 26, 1995·Science·J D KatzD Mathis
Jan 1, 1994·Diabetic Medicine : a Journal of the British Diabetic Association·J A Todd
Jun 1, 1993·Journal of Autoimmunity·N N ShehadehK J Lafferty

❮ Previous
Next ❯

Citations

Dec 26, 2001·Transplantation Proceedings·L C Paul
May 22, 1998·Transplantation Proceedings·H SchorlemmerR Kurrle
Jun 24, 1998·Transplantation Proceedings·H U Schorlemmer, R Kurrle
Nov 27, 1999·Transplantation Proceedings·L C Paul
Mar 29, 2003·Scandinavian Journal of Immunology·C RietzC Fernández
Jun 7, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sue TsaiPere Santamaria

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.